Stock CDNA CAREDX, INC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
14.83 USD +34.09% Intraday chart for CareDx, Inc +52.57% +23.58%
May. 10 Sector Update: Health Care Stocks Higher Late Afternoon MT
May. 10 CareDx Shares Rise After Q1 Results Beat Estimates MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CareDx: Q1 Earnings Snapshot
AQ
CareDx Reports First Quarter 2024 Results
BU
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
CareDx to Report First Quarter 2024 Financial Results
BU
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
BU
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
BU
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
BU
CareDx Appoints Bryan Riggsbee to Its Board of Directors
BU
CareDx : Appoints Bryan Riggsbee to Its Board of Directors - Form 8-K
PU
CareDx : Corporate Presentation February 2024
PU
CareDx: Q4 Earnings Snapshot
AQ
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
BU
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
BU
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
BU
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
BU
Jury Rules in Favor of Natera in Patent Infringement Lawsuit against CareDx, Awards $96.3 Million in Damages to Natera in Lost Profits and Past Royalties
AQ
CareDx Issues Statement in Patent Infringement Case
BU
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
BU
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
BU
In Patent Eligibility It's The Claim That Is The Name Of The Game*
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CDNA Stock
  4. News CareDx, Inc
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW